rdf:type |
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0008976,
umls-concept:C0040808,
umls-concept:C0215136,
umls-concept:C0332283,
umls-concept:C0449820,
umls-concept:C0543467,
umls-concept:C0746319,
umls-concept:C1516213,
umls-concept:C1707455,
umls-concept:C1880594
|
pubmed:issue |
5
|
pubmed:dateCreated |
2011-8-15
|
pubmed:abstractText |
To examine health-related quality of life, we investigated the effect of adjuvant chemotherapy regimens on utility scores assessed by the EuroQoL-5D (EQ-5D) instrument in a randomized, controlled trial for breast cancer patients after surgery. We also investigated the relationship between Functional Assessment of Cancer Therapy (FACT) scale scores and EQ-5D utilities.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1524-4733
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2011 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
746-51
|
pubmed:meshHeading |
pubmed-meshheading:21839414-Adult,
pubmed-meshheading:21839414-Anthracyclines,
pubmed-meshheading:21839414-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21839414-Breast Neoplasms,
pubmed-meshheading:21839414-Chemotherapy, Adjuvant,
pubmed-meshheading:21839414-Disease-Free Survival,
pubmed-meshheading:21839414-Female,
pubmed-meshheading:21839414-Health Status,
pubmed-meshheading:21839414-Health Status Indicators,
pubmed-meshheading:21839414-Humans,
pubmed-meshheading:21839414-Linear Models,
pubmed-meshheading:21839414-Lymphatic Metastasis,
pubmed-meshheading:21839414-Mastectomy,
pubmed-meshheading:21839414-Middle Aged,
pubmed-meshheading:21839414-Predictive Value of Tests,
pubmed-meshheading:21839414-Quality of Life,
pubmed-meshheading:21839414-Questionnaires,
pubmed-meshheading:21839414-Taxoids,
pubmed-meshheading:21839414-Time Factors,
pubmed-meshheading:21839414-Treatment Outcome
|
pubmed:articleTitle |
Comparison of EQ-5D scores among anthracycline-containing regimens followed by taxane and taxane-only regimens for node-positive breast cancer patients after surgery: the N-SAS BC 02 trial.
|
pubmed:affiliation |
Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University, Shiga, Japan. t.shiroiwa@gmail.com
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|